This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Drüeke TB et al. (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355: 2071–2084
Singh AK et al. (2006) Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355: 2085–2098
Foley RN et al. (2000) Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int 58: 1325–1335
Levin A (2007) Understanding recent haemoglobin trials in CKD: methods and lesson learned from CREATE and CHOIR. Nephrol Dial Transplant 22: 309–312
Acknowledgements
The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice. The author of the commentary is in no way related to the author of the original article.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author has served on speakers bureaux for Amgen, Janssen-Cilag, Ortho Biotech and Roche; has received grant/research support from Janssen-Cilag, Ortho Biotech and Roche; and has served as a consultant for Ortho Biotech and Roche.
Rights and permissions
About this article
Cite this article
Levin, A. Management of anemia with intravenous methoxy polyethylene glycol–epoetin beta in patients on dialysis. Nat Rev Nephrol 4, 186–187 (2008). https://doi.org/10.1038/ncpneph0761
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0761